BACKGROUND: In 2015 and 2016, Colombia had a widespread outbreak of Zika virus. Data from two national population-based surveillance systems for symptomatic Zika virus disease (ZVD) and birth defects provided complementary information on the effect of the Zika virus outbreak on pregnancies and infant outcomes. METHODS: We collected national surveillance data regarding cases of pregnant women with ZVD that were reported during the period from June 2015 through July 2016. The presence of Zika virus RNA was identified in a subgroup of these women on real-time reverse-transcriptase-polymerase-chain-reaction (rRT-PCR) assay. Brain or eye defects in infants and fetuses and other adverse pregnancy outcomes were identified among the women who had laboratory-confirmed ZVD and for whom data were available regarding pregnancy outcomes. We compared the nationwide prevalence of brain and eye defects during the outbreak with the prevalence both before and after the outbreak period. RESULTS: Of 18,117 pregnant women with ZVD, the presence of Zika virus was confirmed in 5926 (33%) on rRT-PCR. Of the 5673 pregnancies with laboratory-confirmed ZVD for which outcomes had been reported, 93 infants or fetuses (2%) had brain or eye defects. The incidence of brain or eye defects was higher among pregnancies in which the mother had an onset of ZVD symptoms in the first trimester than in those with an onset during the second or third trimester (3% vs. 1%). A total of 172 of 5673 pregnancies (3%) resulted in pregnancy loss; after the exclusion of pregnancies affected by birth defects, 409 of 5426 (8%) resulted in preterm birth and 333 of 5426 (6%) in low birth weight. The prevalence of brain or eye defects during the outbreak was 13 per 10,000 live births, as compared with a prevalence of 8 per 10,000 live births before the outbreak and 11 per 10,000 live births after the outbreak. CONCLUSIONS: In pregnant women with laboratory-confirmed ZVD, brain or eye defects in infants or fetuses were more common during the Zika virus outbreak than during the periods immediately before and after the outbreak. The frequency of such defects was increased among women with a symptom onset early in pregnancy. (Funded by the Colombian Instituto Nacional de Salud and the Centers for Disease Control and Prevention.).
BACKGROUND: In 2015 and 2016, Colombia had a widespread outbreak of Zika virus. Data from two national population-based surveillance systems for symptomatic Zika virus disease (ZVD) and birth defects provided complementary information on the effect of the Zika virus outbreak on pregnancies and infant outcomes. METHODS: We collected national surveillance data regarding cases of pregnant women with ZVD that were reported during the period from June 2015 through July 2016. The presence of Zika virus RNA was identified in a subgroup of these women on real-time reverse-transcriptase-polymerase-chain-reaction (rRT-PCR) assay. Brain or eye defects in infants and fetuses and other adverse pregnancy outcomes were identified among the women who had laboratory-confirmed ZVD and for whom data were available regarding pregnancy outcomes. We compared the nationwide prevalence of brain and eye defects during the outbreak with the prevalence both before and after the outbreak period. RESULTS: Of 18,117 pregnant women with ZVD, the presence of Zika virus was confirmed in 5926 (33%) on rRT-PCR. Of the 5673 pregnancies with laboratory-confirmed ZVD for which outcomes had been reported, 93 infants or fetuses (2%) had brain or eye defects. The incidence of brain or eye defects was higher among pregnancies in which the mother had an onset of ZVD symptoms in the first trimester than in those with an onset during the second or third trimester (3% vs. 1%). A total of 172 of 5673 pregnancies (3%) resulted in pregnancy loss; after the exclusion of pregnancies affected by birth defects, 409 of 5426 (8%) resulted in preterm birth and 333 of 5426 (6%) in low birth weight. The prevalence of brain or eye defects during the outbreak was 13 per 10,000 live births, as compared with a prevalence of 8 per 10,000 live births before the outbreak and 11 per 10,000 live births after the outbreak. CONCLUSIONS: In pregnant women with laboratory-confirmed ZVD, brain or eye defects in infants or fetuses were more common during the Zika virus outbreak than during the periods immediately before and after the outbreak. The frequency of such defects was increased among women with a symptom onset early in pregnancy. (Funded by the Colombian Instituto Nacional de Salud and the Centers for Disease Control and Prevention.).
Authors: Esther Liliana Cuevas; Van T Tong; Nathaly Rozo; Diana Valencia; Oscar Pacheco; Suzanne M Gilboa; Marcela Mercado; Christina M Renquist; Maritza González; Elizabeth C Ailes; Carolina Duarte; Valerie Godoshian; Christina L Sancken; Angelica Maria Rico Turca; Dinorah L Calles; Martha Ayala; Paula Morgan; Erika Natalia Tolosa Perez; Hernan Quijada Bonilla; Ruben Caceres Gomez; Ana Carolina Estupiñan; Maria Luz Gunturiz; Dana Meaney-Delman; Denise J Jamieson; Margaret A Honein; Martha Lucia Ospina Martínez Journal: MMWR Morb Mortal Wkly Rep Date: 2016-12-16 Impact factor: 17.586
Authors: Oscar Pacheco; Mauricio Beltrán; Christina A Nelson; Diana Valencia; Natalia Tolosa; Sherry L Farr; Ana V Padilla; Van T Tong; Esther L Cuevas; Andrés Espinosa-Bode; Lissethe Pardo; Angélica Rico; Jennita Reefhuis; Maritza González; Marcela Mercado; Pablo Chaparro; Mancel Martínez Duran; Carol Y Rao; María M Muñoz; Ann M Powers; Claudia Cuéllar; Rita Helfand; Claudia Huguett; Denise J Jamieson; Margaret A Honein; Martha L Ospina Martínez Journal: N Engl J Med Date: 2016-06-15 Impact factor: 91.245
Authors: Guilherme Calvet; Renato S Aguiar; Adriana S O Melo; Simone A Sampaio; Ivano de Filippis; Allison Fabri; Eliane S M Araujo; Patricia C de Sequeira; Marcos C L de Mendonça; Louisi de Oliveira; Diogo A Tschoeke; Carlos G Schrago; Fabiano L Thompson; Patricia Brasil; Flavia B Dos Santos; Rita M R Nogueira; Amilcar Tanuri; Ana M B de Filippis Journal: Lancet Infect Dis Date: 2016-02-18 Impact factor: 25.071
Authors: Margaret A Honein; April L Dawson; Emily E Petersen; Abbey M Jones; Ellen H Lee; Mahsa M Yazdy; Nina Ahmad; Jennifer Macdonald; Nicole Evert; Andrea Bingham; Sascha R Ellington; Carrie K Shapiro-Mendoza; Titilope Oduyebo; Anne D Fine; Catherine M Brown; Jamie N Sommer; Jyoti Gupta; Philip Cavicchia; Sally Slavinski; Jennifer L White; S Michele Owen; Lyle R Petersen; Coleen Boyle; Dana Meaney-Delman; Denise J Jamieson Journal: JAMA Date: 2017-01-03 Impact factor: 56.272
Authors: Giovanny V A França; Lavinia Schuler-Faccini; Wanderson K Oliveira; Claudio M P Henriques; Eduardo H Carmo; Vaneide D Pedi; Marília L Nunes; Marcia C Castro; Suzanne Serruya; Mariângela F Silveira; Fernando C Barros; Cesar G Victora Journal: Lancet Date: 2016-06-29 Impact factor: 79.321
Authors: Megan R Reynolds; Abbey M Jones; Emily E Petersen; Ellen H Lee; Marion E Rice; Andrea Bingham; Sascha R Ellington; Nicole Evert; Sarah Reagan-Steiner; Titilope Oduyebo; Catherine M Brown; Stacey Martin; Nina Ahmad; Julu Bhatnagar; Jennifer Macdonald; Carolyn Gould; Anne D Fine; Kara D Polen; Heather Lake-Burger; Christina L Hillard; Noemi Hall; Mahsa M Yazdy; Karnesha Slaughter; Jamie N Sommer; Alys Adamski; Meghan Raycraft; Shannon Fleck-Derderian; Jyoti Gupta; Kimberly Newsome; Madelyn Baez-Santiago; Sally Slavinski; Jennifer L White; Cynthia A Moore; Carrie K Shapiro-Mendoza; Lyle Petersen; Coleen Boyle; Denise J Jamieson; Dana Meaney-Delman; Margaret A Honein Journal: MMWR Morb Mortal Wkly Rep Date: 2017-04-07 Impact factor: 17.586
Authors: Tyler M Sharp; Marc Fischer; Jorge L Muñoz-Jordán; Gabriela Paz-Bailey; J Erin Staples; Christopher J Gregory; Stephen H Waterman Journal: MMWR Recomm Rep Date: 2019-06-14
Authors: Gilberto A Santiago; Jesús Vázquez; Sean Courtney; Katia Y Matías; Lauren E Andersen; Candimar Colón; Angela E Butler; Rebecca Roulo; John Bowzard; Julie M Villanueva; Jorge L Muñoz-Jordan Journal: Nat Commun Date: 2018-04-11 Impact factor: 14.919
Authors: Marlos Melo Martins; Antonio José Ledo Alves da Cunha; Jaqueline Rodrigues Robaina; Carlos Eduardo Raymundo; Arnaldo Prata Barbosa; Roberto de Andrade Medronho Journal: PLoS One Date: 2021-02-19 Impact factor: 3.240
Authors: Yasmin Notarbartolo di Villarosa do Amaral; Jocieli Malacarne; Paloma Glauca Brandão; Patrícia Brasil; Karin Nielsen-Saines; Maria Elisabeth Lopes Moreira Journal: Front Psychiatry Date: 2021-08-30 Impact factor: 5.435
Authors: Ellie K Bohm; Jennifer T Vangorder-Braid; Anna S Jaeger; Ryan V Moriarty; John J Baczenas; Natalie C Bennett; Shelby L O'Connor; Michael K Fritsch; Nicole A Fuhler; Kevin K Noguchi; Matthew T Aliota Journal: J Virol Date: 2021-08-11 Impact factor: 5.103
Authors: Luis Alfonso Díaz-Martínez; Mario Augusto Rojas; Luz Stella Pinilla-García; Carlos Hernán Becerra-Mojica; Luis Alfonso Pérez-Vera; Luz Ángela Gutiérrez-Sánchez; Gustavo Adolfo Contreras-García; Carol Gisela Rueda-Ordoñez; Luis Villar Journal: PLoS Negl Trop Dis Date: 2022-03-07
Authors: Christina M Newman; Alice F Tarantal; Michele L Martinez; Heather A Simmons; Terry K Morgan; Xiankun Zeng; Jenna R Rosinski; Mason I Bliss; Ellie K Bohm; Dawn M Dudley; Matthew T Aliota; Thomas C Friedrich; Christopher J Miller; David H O'Connor Journal: Front Immunol Date: 2021-05-17 Impact factor: 7.561